ABBV News and Press, AbbVie Inc. From 02/04/26

2026-02-04 18:04:48 ET The last time I spoke about AbbVie Inc. ( ABBV ) it was in a Seeking Alpha article entitled as " AbbVie: Increased Outlook For 2025 And Expansions Merit Continued 'Strong Buy' Rating ." For this article I had noted a Strong Buy rating on the stock, des...

2026-02-04 17:45:04 ET Investment Overview Earlier this week I discussed my holding of AbbVie Inc. ( ABBV ) stock with members of the Seeking Alpha investing group I run, Haggerston BioHealth.... Read the full article on Seeking Alpha For further details see: Abb...

2026-02-04 15:39:52 ET When I last assessed AbbVie Inc. ( ABBV ), I was focused on VENCLEXTA, an oncology drug that the company was hoping to expand into myelodysplastic syndrome, or MDS. As it turned out, the Phase 3 registration-enabling VERONA trial flunked, leaving the blockbust...

2026-02-04 14:15:02 ET Evercore ISI analyst issues OUTPERFORM recommendation for ABBV on February 4, 2026 07:35PM ET. The previous analyst recommendation was Outperform. ABBV was trading at $218.69 at issue of the analyst recommendation. The overall analyst consensus : B...

2026-02-04 13:21:34 ET More on AbbVie AbbVie Inc. (ABBV) Q4 2025 Earnings Call Transcript AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie nears five-month low as Humira drives Q4...

2026-02-04 13:20:43 ET AbbVie Inc. (ABBV) Q4 2025 Earnings Call February 4, 2026 9:00 AM EST Company Participants Elizabeth Shea - Senior Vice President of Investor Relations Robert Michael - CEO & Chairman of the Board Jeffrey Stewart - Executive VP & Chie...

2026-02-04 12:34:29 ET More on AbbVie AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie: Rocky Near-Term, Positive Long-Term AbbVie posts Q4 beat as Humira outperforms AbbV...

2026-02-04 10:52:26 ET Image source: The Motley Fool. Wednesday, Feb. 4, 2026 at 9 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-04 10:08:38 ET More on markets Risk-Off Flows And A Tech/AI Panic - Market Reactions Dow Jones And U.S. Index Outlook: Major Rotation Flows And Drops How I Use XLB As A Leading Indicator For S&P 500 Trump files $10B lawsuit against IRS, Treasury D...

2026-02-04 08:24:03 ET More on AbbVie AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie: Rocky Near-Term, Positive Long-Term AbbVie Non-GAAP EPS of $2.71 beats by $0.06, revenue of...